Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Vanguard Materials ETF
VAW
$3.11B
| $380K | ﹤0.01% |
2,015
-208
| -9% | -$40.3K |
|
|
NGD
3152
DELISTED
New Gold Inc
NGD
| $378K | ﹤0.01% |
+102,344
| New | +$303K |
|
3153
Maui Land & Pineapple Co
MLP
$343M
| $377K | ﹤0.01% |
21,462
-740
| -3% | -$14.4K |
|
3154
Vanguard Energy ETF
VDE
$9.69B
| $374K | ﹤0.01% |
2,885
-470
| -14% | -$59.3K |
|
3155
Fennec Pharmaceuticals
FENC
$365M
| $372K | ﹤0.01% |
61,146
| – | – |
|
3156
Zura Bio
ZURA
$536M
| $372K | ﹤0.01% |
288,601
-7,560
| -3% | -$11.9K |
|
3157
Acacia Research
ACTG
$439M
| $370K | ﹤0.01% |
115,494
-6,952
| -6% | -$28.4K |
|
3158
Rocky Brands
RCKY
$374M
| $367K | ﹤0.01% |
21,138
+1,563
| +8% | +$34.1K |
|
3159
Cadiz
CDZI
$273M
| $366K | ﹤0.01% |
124,882
+25
| +0% | +$110 |
|
3160
Pioneer Bancorp
PBFS
$431M
| $364K | ﹤0.01% |
31,074
-983
| -3% | -$11.4K |
|
3161
Global Water Resources
GWRS
$211M
| $362K | ﹤0.01% |
35,075
+4,424
| +14% | +$50.3K |
|
3162
Lifezone Metals
LZM
$355M
| $361K | ﹤0.01% |
86,329
| – | – |
|
3163
Concrete Pumping Holdings
BBCP
$491M
| $359K | ﹤0.01% |
65,736
| – | – |
|
|
CTNM
3164
Contineum Therapeutics
CTNM
$574M
| $357K | ﹤0.01% |
51,202
-4,128
| -7% | -$37.5K |
|
3165
Eastern Company
EML
$147M
| $355K | ﹤0.01% |
14,020
| – | – |
|
3166
Clarus
CLAR
$129M
| $351K | ﹤0.01% |
93,643
+21,508
| +30% | +$96.5K |
|
3167
Sanara MedTech
SMTI
$313M
| $351K | ﹤0.01% |
11,356
| – | – |
|
3168
Puma Biotechnology
PBYI
$407M
| $350K | ﹤0.01% |
118,254
+588
| +0.5% | +$1.84K |
|
3169
MediWound
MDWD
$182M
| $349K | ﹤0.01% |
22,468
+3,343
| +17% | +$59.8K |
|
|
TE
3170
T1 Energy
TE
$1.53B
| $348K | ﹤0.01% |
276,372
+11,867
| +4% | +$21.9K |
|
3171
SEACOR Marine Holdings
SMHI
$256M
| $348K | ﹤0.01% |
68,769
+2
| +0% | +$12 |
|
3172
Alta Equipment Group
ALTG
$243M
| $347K | ﹤0.01% |
73,898
| – | – |
|
3173
Vanguard International High Dividend Yield ETF
VYMI
$20.7B
| $345K | ﹤0.01% |
4,685
-53
| -1% | -$3.81K |
|
3174
WPP
WPP
$4.45B
| $342K | ﹤0.01% |
9,008
-9,929
| -52% | -$442K |
|
3175
Birkenstock
BIRK
$6.89B
| $342K | ﹤0.01% |
7,455
+681
| +10% | +$35.9K |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.